Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Liraglutide · dosing reference

What dose information exists for Liraglutide?

An approved drug with a labelled dose schedule. The label is the authoritative source; research-chemical copies of liraglutide are not the labelled product.

Official product dosing

Official

Approved indication, route, dose, frequency and titration, sourced only from the FDA label, DailyMed or the manufacturer's prescribing information.

Official labelVICTOZA (liraglutide) injection
Approved indication
Adjunct to diet and exercise to improve glycaemic control in patients 10 years and older with type 2 diabetes; reduce risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Route
Subcutaneous injection
Dose
Adults: initiate 0.6 mg once daily, then 1.2 mg once daily; may increase to 1.8 mg once daily if additional glycaemic control is needed. Paediatric (10+): same 0.6 → 1.2 → 1.8 mg escalation.
Frequency
Once daily, any time of day, independent of meals
Titration
0.6 mg daily for one week → 1.2 mg daily; after at least one week, may increase to 1.8 mg daily.
  • Strength: 6 mg/mL solution in a pre-filled pen delivering 0.6, 1.2 or 1.8 mg.
  • The label also carries a boxed warning (thyroid C-cell tumours) and contraindications; the label itself is the complete statement.
Official labelSAXENDA (liraglutide) injection
Approved indication
Chronic weight management in specified adult and paediatric populations, as adjunct to reduced-calorie diet and increased physical activity.
Route
Subcutaneous injection
Dose
Maintenance 3.0 mg once daily after weekly escalation, per label titration schedule.
Frequency
Once daily
Titration
Weekly escalation 0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg, per the label's dose-escalation table.

Why community reports are shown at all

People search for dose information before they search for anything else in this sector. Where discussion is widespread, pretending it does not exist helps nobody. Therapept reports the discussion — its rough shape, how common it is, and where it happens — while keeping it visibly separate from every other kind of source. Community reports describe what people say they are doing. They are not equivalent to clinical evidence.

Last reviewed 17 September 2026 · Compiled by Therapept Editorial · How these records are built